Login or Sign Up
15:44 Dec 05
Remus Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Remus Pharmaceuticals Ltd. Financials
Remus Pharmaceuticals Ltd.
Industry Pharmaceuticals
15:44 Dec 05
Quality
0/100
Not Eligible
Valuation
23/100
Expensive Valuation
Technical
29/100
Technically Bearish
Strength
2
Weakness
5
Opportunity
0
Threats
0
11.36 %
ROE %
6.71 %
ROA %
24.67
EPS
434.40
BVPS
4.68 %
Net Profit Margin
| Mar 2024 | Mar 2025 | ||
|---|---|---|---|
| Net Sales | 212.5 | 620.36 | |
| Operating Expenses + | 184.69 | 574.67 | |
| Raw Material | 164.99 | 541.31 | |
| Increase Decrease in Cost | -0.67 | -8.44 | |
| Other Manufacturing Expense | 0 | 0 | |
| Employee Cost | 7.42 | 13.11 | |
| Miscellaneous Expenses | 342.93 | 1111.31 | |
| Operating Profit | 27.81 | 45.69 | |
| Other Income | 5.4 | 4.98 | |
| Depreciation | 0.9 | 1.87 | |
| Interest | 0.48 | 1.46 | |
| Profit before tax and exceptio.. | 31.83 | 47.34 | |
| Exceptional Items | 0 | 0 | |
| PBT | 31.83 | 47.34 | |
| Provision for Taxation | 5.85 | 8.92 | |
| Net Profit | 25.98 | 38.42 | |
| NET Profit after MI | 25.98 | 29.07 | |
| EPS | 152.01 | 65.21 | |
| Operating Profit Margin (%) | 13.09 | 7.37 | |
| Net Profit Margin (%) | 12.23 | 4.69 |
Remus Pharmaceuticals Ltd. Shareholding
Promoter
FII
Public
All Data in Percentage (%)
| Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|
| Promoter | 70.90 | 70.80 | 70.80 | 70.60 |
| FII | 5.00 | 4.80 | 3.20 | 3.20 |
| Public | 0.80 | 0.70 | 0.70 | 0.70 |
| Others | 23.30 | 23.70 | 25.30 | 25.50 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully